Use of Epothilones in the treatment of bone metastases and bone tumors or cancers

Details for Australian Patent Application No. 2005287477 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Pietsch, Hubertus; Hoffmann, Jens; Klar, Ulrich

Agent Davies Collison Cave

Pub. Number AU-A-2005287477

PCT Pub. Number WO2006/032537

Priority 04090377.5 24.09.04 EP

Filing date 22 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/032537 Priority application(s): WO2006/032537

24 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287478-Methods and means for producing hyaluronan

2005287473-Novel vaccine for veterinary and human medicine prophylaxis and therapy